Bionano Genomics (BNGO)
(Delayed Data from NSDQ)
$0.42 USD
-0.01 (-1.82%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $0.42 0.00 (-0.14%) 7:36 PM ET
2-Buy of 5 2
F Value B Growth A Momentum C VGM
Price, Consensus and EPS Surprise
BNGO 0.42 -0.01(-1.82%)
Will BNGO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for BNGO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for BNGO
Bionano Genomics (BNGO) Upgraded to Buy: Here's Why
Is AbCellera Biologics (ABCL) Outperforming Other Medical Stocks This Year?
BNGO: What are Zacks experts saying now?
Zacks Private Portfolio Services
After Plunging -23.84% in 4 Weeks, Here's Why the Trend Might Reverse for Bionano Genomics, Inc. (BNGO)
Analysts Estimate Viridian Therapeutics, Inc. (VRDN) to Report a Decline in Earnings: What to Look Out for
Will Bionano Genomics, Inc. (BNGO) Report Negative Q3 Earnings? What You Should Know
Other News for BNGO
Buy Rating Affirmed for BioNano Genomics Amidst Operational Progress and Strategic Financial Planning
Bionano Genomics, Inc. (BNGO) Canaccord Genuity 44th Annual Growth Conference (Transcript)
Maxim Group Reaffirms Their Hold Rating on BioNano Genomics (BNGO)
Bionano Genomics price target lowered by $1.60 at Ladenburg, here's why
Bionano Reports Second Quarter 2024 Results and Highlights Recent Business Progress